Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers
Background Our previous study showed that transmembrane tumor necrosis factor alpha (tmTNF-α) is overexpressed in primary breast cancers including triple-negative breast cancers (TNBCs). Chimeric antigen receptor engineered-T (CAR-T) cells have been successfully used mainly in B-cell malignancies.Me...
Main Authors: | Jing Wang, Peng Zhang, Xiaoxi Zhou, Hongping Ba, Zigang Dai, Zunyue Zhang, Bingjiao Yin, Zhuoya Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/1/e003837.full |
Similar Items
-
Suppression of Transmembrane Tumor Necrosis Factor Alpha Processing by a Specific Antibody Protects Against Colitis-Associated Cancer
by: Hongping Ba, et al.
Published: (2021-10-01) -
Transmembrane tumor necrosis factor alpha attenuates pressure-overload cardiac hypertrophy via tumor necrosis factor receptor 2.
by: Kun Miao, et al.
Published: (2020-12-01) -
Modulating the tumor microenvironment improves antitumor effect of anti-PD-L1 mAb in breast cancer
by: Xiuying Li, et al.
Published: (2023-03-01) -
Anti-CD40 mAb enhanced efficacy of anti-PD1 against osteosarcoma
by: Jingzhe Zhang, et al.
Published: (2019-08-01) -
IL36 Cooperates With Anti-CTLA-4 mAbs to Facilitate Antitumor Immune Responses
by: Qiuxia Qu, et al.
Published: (2020-04-01)